ArkeaBio raises $15M for cow-burp vaccine, cuts a third of staff
What's the deal? ArkeaBio, a Boston-based startup developing a vaccine to cut methane emissions from livestock, has raised US$9.71M Series A2 round. AgriZeroNZDealroom has a profile for this one. Try Dealroom → led the round, with support from Breakthrough Energy.
What's the endgame? The vaccine prompts a cow's immune system to interfere with methanogens — the rumen microbes that convert hydrogen into methane, which cattle then belch out. ArkeaBio's first product targets a 10-15% reduction in methane, focusing on New Zealand as its initial market.
Why a vaccine? Chief executive officer Frank Wooten argues it is the most cost-effective way to tackle the problem at scale. "Vaccines are already used in 100% of livestock markets worldwide," he told AgFunderNews, noting that most animals outside the US never go on feed — limiting the reach of feed additives.
The layoffs: ArkeaBio has cut its headcount by about a third as it moves toward commercialisation. "We had to pare back some of our initiatives and really hone in on our initial market, initial product and critically initial revenues," Wooten said, adding that the cuts included "some really great scientists as well as commercial folks."
What's the money for? The round is expected to carry ArkeaBio through its first commercial product. "This round is likely to take us through the first commercial product," Wooten said.
What could go wrong? A 10-15% reduction trails rivals: feed additive BovaerDealroom has a profile for this one. Try Dealroom → promises 30% in lactating dairy cattle, and some seaweed products claim up to 90%. Commercial viability also hinges on dosing frequency — the initial product lasts three months, with a six-month version planned next.
The signal: ArkeaBio is betting that ease of adoption, not headline efficacy, wins the livestock methane market. In a tight funding climate, the company is trading scientific breadth for runway — narrowing to one market, one product, and early revenue to reach commercialisation.
Read more: agfundernews.com
Image credit: Generated with Gemini
